Ceria Therapeutics

Ceria Therapeutics

Pre-clinical
Cambridge, United StatesFounded 2021ceriatherapeutics.com

Ceria develops innovative drug products to eliminate downstream consequences and restore the body’s natural healing. In addition to these therapeutic programs, Ceria provides comprehensive synthetic RNA and nanoparticle manufacturing capabilities—including scalable production, solid inorganic nanoparticle synthesis, and analytical methods. Capabilities include aerosolized drug formulation, particle characterization, and preclinical testing. These combine to enable product development support ...

Founded
2021
Focus
RNA & Gene Therapy

About

Ceria develops innovative drug products to eliminate downstream consequences and restore the body’s natural healing. In addition to these therapeutic programs, Ceria provides comprehensive synthetic RNA and nanoparticle manufacturing capabilities—including scalable production, solid inorganic nanoparticle synthesis, and analytical methods. Capabilities include aerosolized drug formulation, particle characterization, and preclinical testing. These combine to enable product development support ...

Funding History

2

Total raised: $6.5M

Grant$2.5MNational Institutes of HealthApr 15, 2022
Seed$4MUndisclosedAug 15, 2021

Company Info

TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile